| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0071 | 0.9 |